The Journal of Organic Chemistry · 2015 · 34 citations · 44 references
PharmacyChemistryMedicinal ChemistryCatalysisDrug DiscoveryOrganometallic ChemistryCatalytic MechanismsMichaelis-menten KineticsAldol ReactionPhosphate Buffer SystemPyrazole ChemistryPyrazole SynthesisStereoselective Aldol Reactions
A new and versatile class of HNO donors, the (hydroxylamino)pyrazolone (HAPY) series of HNO donors utilizing pyrazolone (PY) leaving groups, is described. HNO, the smallest N-based aldehyde equivalent, is used as a reagent along with a variety of PY compounds to synthesize the desired HAPY donors in what can be considered an N-selective HNO-aldol reaction in up to quantitative yields. The bimolecular rate constant of HNO with PY in pH 7.4 phosphate buffer at 37 °C can reach 8 × 10(5) M(-1) s(-1). In (1)H NMR experiments, the HAPY compounds generate HNO quantitatively (trapped as a phosphine aza-ylide) with half-lives spanning 3 orders of magnitude (minutes to days) under physiologically relevant conditions. B3LYP/6-31G* calculations confirm the energetically favorable reactions between HNO and the PY enol and enolate, whereas HNO release is expected to occur through the oxyanion (OHN-PY) of each HAPY compound. HNO has been shown to provide functional support to failing hearts.
44
Forecasting the Future of Cardiovascular Disease in the United States
Paul A. Heidenreich, Justin G. Trogdon, Olga Khavjou et al. · Circulation · 2011 · 3.2K citations · Full text
The emerging biology of the nitrite anion
Mark T. Gladwin, Alan N. Schechter, Daniel B. Kim‐Shapiro et al. · Nature Chemical Biology · 2005 · 605 citations
Clinical epidemiology of heart failure: public and private health burden.
John J.V. McMurray, Mark C. Petrie, David R. Murdoch et al. · PubMed · 1998 · 374 citations